Netenax (Netilmicin)

Netilmicin, the active ingredient in Netenax, is an aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It is employed to treat bacterial infections of the eye, including conjunctivitis and keratitis, in adult patients.

GNH USA supplies Netenax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory‑aligned logistics, and stringent quality‑control in line with EU manufacturing standards. Our global network facilitates timely delivery to meet clinical demand.

Netenax is indicated for bacterial eye infections, targeting pathogens that affect the ocular surface and cornea.

- Bacterial conjunctivitis: reduces bacterial load and alleviates redness and discharge. - Corneal ulcer (bacterial keratitis): promotes healing of infected corneal tissue. - Post‑operative ocular infection: prevents or treats bacterial contamination after eye surgery.

Netenax may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Transient burning or stinging on instillation - Mild conjunctival hyperemia - Tearing or increased lacrimation - Temporary blurred vision - Foreign body sensation

Serious or Rare Side Effects: - Corneal epithelial toxicity - Severe allergic reaction (anaphylaxis) with swelling and itching - Persistent keratitis - Vision loss - Systemic ototoxicity (rare with extensive use)

Before prescribing Netenax, clinicians should consider the following precautions to ensure safe use.

- Allergy assessment: confirm no known hypersensitivity to aminoglycosides or Netilmicin. - Contact lens wearers: advise removal before instillation and avoid re‑insertion until after dosing. - Corneal epithelial defects: use with caution as drug may delay healing. - Concurrent ototoxic drugs: monitor for additive toxicity if systemic exposure possible. - Pregnancy and lactation: evaluate risk‑benefit as safety data are limited. - Store at below 25°C: keep in original container, protect from moisture and light.

Netenax can interact with other medications, affecting efficacy or safety.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase risk of ototoxicity and nephrotoxicity. - Topical ophthalmic anesthetics: may enhance corneal toxicity when combined. - Other topical antibiotics: may reduce antimicrobial effectiveness due to antagonism.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: monitor for delayed wound healing. - Corticosteroid eye drops: may mask signs of infection, requiring close observation. - Systemic loop diuretics: monitor renal function if systemic absorption is suspected.